Zhu H, Li C, Hu F, Wu L, Wu L, Zhou M
In Vitro Cell Dev Biol Anim. 2024; 61(1):107-116.
PMID: 39621175
DOI: 10.1007/s11626-024-00976-2.
Gaulton T, Xin Y, Victor M, Nova A, Cereda M
Nitric Oxide. 2024; 147:6-12.
PMID: 38588918
PMC: 11253040.
DOI: 10.1016/j.niox.2024.04.004.
Karamooz E, Brixey A, Rydzak C, Primack S, Markwardt S, Barker A
J Thorac Dis. 2024; 16(2):1496-1502.
PMID: 38505050
PMC: 10944741.
DOI: 10.21037/jtd-23-1316.
Ye L, Wang B, Xu H, Zhang X
Metabolites. 2023; 13(11).
PMID: 37999248
PMC: 10672796.
DOI: 10.3390/metabo13111152.
Yen T, Huang H, Wu E, Chou H, Chou H, Chen C
Int J Mol Sci. 2022; 23(18).
PMID: 36142307
PMC: 9499400.
DOI: 10.3390/ijms231810400.
The Cardiovascular and Metabolic Effects of Chronic Hypoxia in Animal Models: A Mini-Review.
Barnes L, Mesarwi O, Sanchez-Azofra A
Front Physiol. 2022; 13:873522.
PMID: 35432002
PMC: 9008331.
DOI: 10.3389/fphys.2022.873522.
Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target.
Karnati S, Seimetz M, Kleefeldt F, Sonawane A, Madhusudhan T, Bachhuka A
Front Cardiovasc Med. 2021; 8:649512.
PMID: 33912600
PMC: 8072123.
DOI: 10.3389/fcvm.2021.649512.
Evaluation of right ventricular performance and impact of continuous positive airway pressure therapy in patients with obstructive sleep apnea living at high altitude.
Chu A, Yu H, Yang H, Tian L, Hu Z, Jiang N
Sci Rep. 2020; 10(1):20186.
PMID: 33214634
PMC: 7678870.
DOI: 10.1038/s41598-020-71584-9.
Comparison of Functional Capacity and Symptoms of COPD Patients with and without Pulmonary Hypertension.
Kalkan F, Yilmazel Ucar E, Kalkan K, Araz O
Eurasian J Med. 2020; 52(2):166-170.
PMID: 32612425
PMC: 7311132.
DOI: 10.5152/eurasianjmed.2020.19391.
Independent lung ventilation with use of a double-lumen endotracheal tube for refractory hypoxemia and shock complicating severe unilateral pneumonia: A case report.
Yoshida M, Taira Y, Ozaki M, Saito H, Kurisu M, Matsushima S
Respir Med Case Rep. 2020; 30:101084.
PMID: 32435582
PMC: 7229276.
DOI: 10.1016/j.rmcr.2020.101084.
NOD2 deficiency exacerbates hypoxia-induced pulmonary hypertension and enhances pulmonary vascular smooth muscle cell proliferation.
Kwon M, Hwang N, Park Y, Perrella M, Chung S
Oncotarget. 2018; 9(16):12671-12681.
PMID: 29560100
PMC: 5849164.
DOI: 10.18632/oncotarget.23912.
Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells.
Li Q, Qian Z, Wang L
Int J Chron Obstruct Pulmon Dis. 2017; 12:1351-1361.
PMID: 28496318
PMC: 5422315.
DOI: 10.2147/COPD.S99318.
Hypoxic Pulmonary Vasoconstriction in Humans: Tale or Myth.
Hussain A, Suleiman M, George S, Loubani M, Morice A
Open Cardiovasc Med J. 2017; 11:1-13.
PMID: 28217180
PMC: 5301302.
DOI: 10.2174/1874192401711010001.
Mechanisms of hypoxemia.
Sarkar M, Niranjan N, Banyal P
Lung India. 2017; 34(1):47-60.
PMID: 28144061
PMC: 5234199.
DOI: 10.4103/0970-2113.197116.
Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
Sedivy V, Joshi S, Ghaly Y, Mizera R, Zaloudikova M, Brennan S
Am J Physiol Lung Cell Mol Physiol. 2014; 308(1):L48-57.
PMID: 25361569
PMC: 4281702.
DOI: 10.1152/ajplung.00362.2013.
Assessment of right ventricular geometry and mechanics in chronic obstructive pulmonary disease patients living at high altitude.
Guvenc T, Kul S, Dogan C, Yildirim B, Karabag Y, Cetin R
Int J Cardiovasc Imaging. 2014; 30(7):1305-13.
PMID: 24950729
DOI: 10.1007/s10554-014-0475-z.
Mechanical ventilation strategy following Glenn and Fontan surgeries: On going challenge!.
Al-Eyadhy A
J Saudi Heart Assoc. 2013; 21(3):153-7.
PMID: 23960565
PMC: 3727352.
DOI: 10.1016/j.jsha.2009.06.005.
Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.
Wan J, Yamamura A, Zimnicka A, Voiriot G, Smith K, Tang H
Am J Physiol Lung Cell Mol Physiol. 2013; 305(2):L154-64.
PMID: 23686856
PMC: 3726947.
DOI: 10.1152/ajplung.00313.2012.
Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension.
Morecroft I, White K, Caruso P, Nilsen M, Loughlin L, Alba R
Mol Ther. 2012; 20(8):1516-28.
PMID: 22525513
PMC: 3412483.
DOI: 10.1038/mt.2012.70.
Hypoxic pulmonary vasoconstriction.
Sylvester J, Shimoda L, Aaronson P, Ward J
Physiol Rev. 2012; 92(1):367-520.
PMID: 22298659
PMC: 9469196.
DOI: 10.1152/physrev.00041.2010.
